|Articles|November 1, 2018
- Pharmaceutical Executive-11-01-2018
- Volume 38
- Issue 11
Pharmaceutical Executive, November 2018 Issue (PDF)
Click the title above to open the Pharmaceutical November 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Pharm Exec's 2019 Pipeline Reportalmost 7 years ago
High-Risk Marketing Violations Draw Scrutinyalmost 7 years ago
Biopharma Business Checkalmost 7 years ago
Patent Protection for Cannabis?almost 7 years ago
Steadying the Path of Good Sciencealmost 7 years ago
Southeast Biotech: Rising Tall in the Valleyalmost 7 years ago
Fighting for a Streamlined European HTA Schemealmost 7 years ago
Stunted Innovation in Drug Development?almost 7 years ago
Country Report: AlgeriaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
All of the Medications Announced as Part of FDA’s National Priority Voucher Program
2
Eli Lilly’s and Novo’s Stocks React to President Trump’s Comments on GLP-1 Prices
3
Autonomous Omnichannel: When AI Thinks for Pharma Marketing
4
EMD Serono Announces Agreement with Trump Administration Increasing Access to In Vitro Fertilization Therapies for US Patients
5
